High-Throughput Mass Spectrometry Analysis of -Glycans and Protein Markers After Knockdown in the Syngeneic SW480/SW620 Colorectal Cancer Cell Model
Overview
Affiliations
Disruption of the glycosylation machinery is a common feature in many types of cancer, and colorectal cancer (CRC) is no exception. Core fucosylation is mediated by the enzyme fucosyltransferase 8 (FucT-8), which catalyzes the addition of α1,6-l-fucose to the innermost GlcNAc residue of -glycans. We and others have documented the involvement of FucT-8 and core-fucosylated proteins in CRC progression, in which we addressed core fucosylation in the syngeneic CRC model formed by SW480 and SW620 tumor cell lines from the perspective of alterations in their -glycosylation profile and protein expression as an effect of the knockdown of the gene that encodes FucT-8. Using label-free, semiquantitative mass spectrometry (MS) analysis, we found noticeable differences in -glycosylation patterns in -knockdown cells, affecting core fucosylation and sialylation, the Hex/HexNAc , and antennarity. Furthermore, stable isotopic labeling of amino acids in cell culture (SILAC)-based proteomic screening detected the alteration of species involved in protein folding, endoplasmic reticulum (ER) and Golgi post-translational stabilization, epithelial polarity, and cellular response to damage and therapy. This data is available via ProteomeXchange with identifier PXD050012. Overall, the results obtained merit further investigation to validate their feasibility as biomarkers of progression and malignization in CRC, as well as their potential usefulness in clinical practice.
Targeting fucosyltransferase FUT8 as a prospective therapeutic approach for DLBCL.
Xu H, Li Q, Zhang Y, He C, Zhang X, Wang Z Oncogenesis. 2025; 14(1):1.
PMID: 39881135 PMC: 11779920. DOI: 10.1038/s41389-025-00544-7.